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Dnmt3a deficiency in the skin causes focal, canonical
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Sai Mukund Ramakrishnanb, Amanda M. Smithb, Christopher A. Millerb, and Timothy J. Leyb,1
a
Division of Dermatology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO 63110; and bSection of Stem Cell Biology,
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DNA hypomethylation is a feature of epidermal cells from aged
and sun-exposed skin, but the mechanisms responsible for this
methylation loss are not known. Dnmt3a is the dominant de novo
DNA methyltransferase in the skin; while epidermal Dnmt3a deficiency creates a premalignant state in which keratinocytes are more
easily transformed by topical mutagens, the conditions responsible
for this increased susceptibility to transformation are not well understood. Using whole genome bisulfite sequencing, we identified a
focal, canonical DNA hypomethylation phenotype in the epidermal
cells of Dnmt3a-deficient mice. Single-cell transcriptomic analysis
revealed an increased proportion of cells with a proliferative gene
expression signature, while other populations in the skin were relatively unchanged. Although total DNMT3A deficiency has not been
described in human disease states, rare patients with an overgrowth syndrome associated with behavioral abnormalities and
an increased risk of cancer often have heterozygous, germline mutations in DNMT3A that reduce its function (Tatton-Brown Rahman
syndrome [TBRS]). We evaluated the DNA methylation phenotype
of the skin from a TBRS patient with a germline DNMT3AR882H mutation, which encodes a dominant-negative protein that reduces its
methyltransferase function by ∼80%. We detected a focal, canonical
hypomethylation phenotype that revealed considerable overlap
with hypomethylated regions found in Dnmt3a-deficient mouse
skin. Together, these data suggest that DNMT3A loss creates a premalignant epigenetic state associated with a hyperproliferative phenotype in the skin and further suggest that DNMT3A acts as a tumor
suppressor in the skin.
DNMT3A

modifying unmethylated cytidine residues in a CpG dinucleotide
context as well as some aspects of maintenance methylation (6,
7). DNA methylation is important for normal skin development
and function. Mice with Dnmt1 deficiency in skin develop progressive alopecia, resulting in >50% hair loss over a year, while
DNMT1 knockdown in human keratinocytes causes premature
differentiation (8, 9). Similarly, the knockdown of either DNMT3A
or DNMT3B reduces the clonogenic potential of cultured human
keratinocytes (10). Importantly, Dnmt3a (but not Dnmt3b) has
tumor suppressor activity in the classic 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)
chemical carcinogenesis model, with shortened latency and a
higher tumor burden in Dnmt3a-deficient skin (11); however, the
precise epigenetic changes that contribute to the premalignant,
susceptible state have not yet been clearly defined.
In humans, there is considerable evidence that alterations in
DNA methylation machinery may play a role in skin cancer pathogenesis. Both precancerous actinic keratoses (AKs) and squamous
cell carcinomas (SCCs) exhibit hypomethylation of CpGs in laminaassociated domains, hypermethylation of CpG islands, and increased
DNMT3B expression (12). DNMT3A is expressed at lower levels
in AKs and SCCs, compared to healthy skin (11). Finally, somatic DNMT3A mutations have been identified in 11% (33/304)
of patients from three studies of basal cell carcinoma (BCC) and
SCC (cbioportal.org); DNMT3B was mutated in 8% (12/146) of
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Keratinocyte carcinomas are the most common malignancies in
fair-skinned patients. Increased age and sun exposure are important skin cancer risk factors and have been associated with
a loss of DNA methylation in the human epidermis. Complete
Dnmt3a deficiency in mouse skin creates a premalignant state,
but the mechanisms responsible for this phenomenon are not
clear. This study demonstrates that Dnmt3a deficiency in murine epidermis causes focal, canonical DNA hypomethylation
and an increased proportion of cells with a proliferative gene
expression signature. Understanding the mechanisms responsible for the premalignant state may be important for defining
novel preventative or therapeutic strategies for skin cancers.
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ging and sun exposure are the most important epidemiologic
risk factors for the development of skin cancer in populations
with lightly pigmented skin. Although there are no registries to
accurately account for the incidence of nonmelanoma skin cancers,
treatment utilization for keratinocyte carcinomas sharply increases
with advancing age (1). The accumulation of genetic mutations from
UV light exposure clearly contributes to age-dependent increases in
skin cancer; however, sun-damaged skin can harbor a remarkable
number of driver mutations while remaining clinically normal (2).
This suggests that nonmutational factors may also influence skin
cancer susceptibility. The contribution of epigenetic perturbations
(including alterations in DNA methylation) to cancer susceptibility is
incompletely understood (3, 4). Aged, sun-exposed epidermal skin
cells in older people develop DNA methylation changes, compared
to the sun-protected skin of younger individuals (5). It is not yet
clear whether altered activity of DNA methyltransferases or demethylases, cellular population shifts, or changes in cellular signaling or
other modifying factors are responsible for this change.
DNA methyltransferases are responsible for CpG methylation
and comprise two functional groups: 1) the maintenance methyltransferase DNMT1, which copies methylation marks to the
CpGs of newly synthesized DNA; and 2) the de novo methyltransferases DNMT3A and DNMT3B, which are responsible for
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cases and DNMT1 in 15% (45/304) (13–15). Many of the mutations in DNMT3A in these tumors were localized to the methyltransferase domain, or were predicted to cause protein truncations
that would be expected to disrupt its function and potentially
cause haploinsufficiency.
Dnmt3a deficiency in murine bone marrow cells results in a
focal, canonical DNA hypomethylation phenotype (16–18) that
is associated with the development of hematopoietic malignancies (17, 19, 20). DNA hypomethylation in Dnmt3a-deficient
marrow is reversible with DNMT3A reexpression, and remethylation occurs in an orderly fashion with predictable kinetics and high
fidelity (18). Germline mutations in DNMT3A are strongly associated with an overgrowth syndrome (Tatton-Brown-Rahman syndrome [TBRS]) that is associated with a potentially increased risk of
acute myeloid leukemia (AML) (21, 22). Finally, acquired mutations of DNMT3A in older individuals are the most common cause
of hematopoietic clonal expansion, which is associated with an increased risk of AML development (23–26). Indeed, DNMT3A
mutations are among the most common initiating mutations in
adults with de novo AML; mutations at amino acid position R882
(most frequently R882H) represent the most common mutational
hot spot in this gene (27).
In this study, we evaluate the premalignant epigenetic phenotype
of Dnmt3a-deficient skin and identify changes that could potentially
contribute to its role in increasing susceptibility to transformation.
We then relate these findings to the skin methylation phenotype of
a TBRS patient with a germline DNMT3AR882H mutation.
Results
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Dnmt3a Deficiency in Epidermal Keratinocytes Results in a Focal,
Canonical DNA Hypomethylation Phenotype. Mice with homozygous

Dnmt3a deficiency develop normally but die within 3 wk of birth
(28). To study the effects of Dnmt3a deficiency in the skin, we
therefore used transgenic mice expressing Cre recombinase under
the control of the Keratin 14 (Krt14) promoter, which exhibits a
well-established pattern of expression that affects the epidermal
skin and its appendages (29). With appropriate crosses, we obtained
mice that were wild type (WT) for Dnmt3a (Krt14-Cre− ×
Dnmt3aflox/flox, hereafter “Dnmt3aWT”), heterozygous (Krt14-Cre+ ×
Dnmt3aflox/+, hereafter “Dnmt3aHET”), or homozygous for the
floxed allele (Krt14-Cre+ × Dnmt3aflox/flox, hereafter “Dnmt3aKO”).
The floxing efficiency of the Dnmt3aflox/flox alleles in epidermal cells
with Krt14-Cre was >90%, resulting in a complete loss of Dnmt3a
protein expression (SI Appendix, Fig. S1A).
Whole genome bisulfite sequencing (WGBS) was used to assess
DNA methylation of isolated murine epidermal cells. Dnmt3aKO
mice exhibited a small but significant decrease in global DNA
methylation in all annotated regions examined, including CpG
islands, island shores, island shelves, gene bodies, promoters, enhancers, and transcriptional start sites (Fig. 1 A, Top). Loss of one
allele of Dnmt3a (Dnmt3aHET) resulted in a statistically significant
change in methylation from the Dnmt3aWT in all regions except
gene bodies. On a global scale, the overall decrease in CpG
methylation was very small, similar to what has been observed in
hematopoietic tissues (Fig. 1 B, Top) (18, 30).
We identified differentially methylated regions (DMRs) between
Dnmt3aWT and Dnmt3aKO samples using previously described
approaches (18, 30). DMRs were defined as having greater than
10 CpGs with a mean methylation difference of more than 0.2
(i.e., 20%) between Dnmt3aWT and Dnmt3aKO skin, with a false
discovery rate (FDR) of less than 0.05. Adjacent DMRs within
50 base pairs were merged. Based on these criteria, we identified
23,983 DMRs with an average size of 0.95 kilobases (Kb),
encompassing 23.53 megabases (Mb) of DNA, which represents
0.87% of the genome (Dataset S1). Virtually all DMRs were
hypomethylated (23,981/23,983; 99.99%), and the degree of
hypomethylation did not vary based on their location in annotated genomic regions (Fig. 1 A, Bottom). Skin from Dnmt3aHET
2 of 10 | PNAS
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mice demonstrated a more subtle methylation phenotype at these
DMRs (Fig. 1 B, Bottom). The DMRs in Dnmt3a-deficient skin are
represented by a heatmap, where each column represents an independent mouse, and each row, the mean methylation value of an
individual DMR for all samples (Fig. 1C). There is remarkable
consistency (i.e., canonicality) among the methylation phenotypes at
each DMR among independent mice with the same genotypes. The
methylation values of the Dnmt3aHET samples are plotted passively
and exhibit an intermediate level of methylation at many DMRs
(Fig. 1C), demonstrating that haploinsufficiency for Dnmt3a also
has a methylation phenotype in the skin (Fig. 1 A and B).
Dnmt3a-dependent DMRs occur most commonly within gene
bodies; 16.4% of all annotated protein-coding genes were found
to have at least one DMR. DNA methylation within most CpG
islands is low in Dnmt3aWT skin, as expected. A small fraction
of these islands (142/16,923; 0.89%) exhibit significantly higher
methylation than total CpG islands in Dnmt3aWT skin, and these
rare islands generally become hypomethylated in Dnmt3aKO skin
(Fig. 1 D and A, Bottom). These DMRs usually represent intragenic CpG islands, of which ∼65% are methylated in human
embryonic stem cells (31). Indeed, 129/142 (91%) Dnmt3aKO
DMRs associated with CpG islands are located within gene bodies. The shores and shelves flanking CpG islands exhibited greater
proportions of DMRs (3.7% and 8.85%, respectively), while the
methylation of transcriptional start sites (TSSs) was minimally
affected by Dnmt3a deficiency (0.86%, Fig. 1D). The methylation
pattern near the G0s2 gene is shown as an example of a Dnmt3aKO
DMR that occurs in a gene body (Fig. 1E). This gene was found to
be up-regulated in Dnmt3aKO skin tumors (11).
Dnmt3a Deficiency Results in a Distinct Transcriptional Phenotype.

Dnmt3a deficiency does not result in any gross abnormalities in
unperturbed skin (11). Further, flow cytometric evaluation of cellular
populations within the skin revealed minimal differences between
Dnmt3aWT and Dnmt3aKO (SI Appendix, Fig. S1B). To interrogate
the transcriptomic consequences of Dnmt3a deficiency, we employed
single-cell RNA sequencing to analyze adult murine epidermis in
telogen (the resting phase of the hair cycle). We analyzed two mice
from each genotype (Dnmt3aWT and Dnmt3aKO) at 9 to 10 wk of
age; 10,482 cells from Dnmt3aWT and 15,403 cells from Dnmt3aKO
met quality standards. Unbiased clustering based on expression
signatures defined subpopulations of cells in the skin (Fig. 2A) that
were remarkably similar among all four samples (Fig. 2B).
Unique populations segregated into distinct clusters with graphbased clustering and are represented by uniform manifold approximation and projection (UMAP) dimension reduction plots
shown in Fig. 2A (32). In total, 19 clusters were identified by unbiased methods (Louvain method graph-based clustering, Dataset
S3), which were subsequently categorized into 10 populations
based on well-established, experimentally validated markers representing known populations in the epidermis (Fig. 2 A, Right).
The hair follicle bulge (HFB) contains follicular stem cells and is
marked by Cd34 expression (33), while the upper hair follicle
(uHF) is marked by beta defensin (Defb6) expression (34, 35).
Subdivided into the isthmus and infundibulum, the upper hair
follicle bridges the follicle with the interfollicular epidermis and
sebaceous gland, which is marked by the expression of Mgst1 (34).
The basal interfollicular epithelium (bIFE) contains slow cycling,
proliferative cells that act as an epidermal stem cell compartment
(36), and is marked by “basal” keratin gene expression (Krt5 and
Krt14), as well as Thbs1 (37). The suprabasal interfollicular epithelium (sbIFE) is postmitotic and marked by the expression of the
genes that encode keratins Krt1 and Krt10 and an early differentiation marker metallothionein Mt4 (34). Melanocytes were marked
by expression of the genes encoding tyrosinase (Tyr) and dopachrome tautomerase (Dct). Inflammatory cells, including T cells
and Cd207-expressing Langerhans cells, comprised 1.3% and 1.1%
of total cells in the samples, respectively. Finally, one population
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Fig. 1. Dnmt3a deficiency results in focal, canonical CpG methylation loss in murine epidermal cells. (A) WGBS of isolated murine epidermal cells, comparing
independent samples from 11 Dnmt3aWT vs. 5 Dnmt3aKO vs. 3 Dnmt3aHET mice. Dot plots represent average methylation values over annotated regions for all
CpGs (Top) and for DMRs within each annotated region (Bottom). Significance was determined by Student’s t test with denotation of “ns” for not significant
and levels of significance as * adjusted P < 0.05, **P < 0.01, ***P < 0.001. (B) Methylation density plots for the indicated genotypes across all genomic CpGs
(Top) and at DMRs (Bottom). (C) Targeted deficiency of Dnmt3a (Krt14-Cre+ × Dnmt3afl/fl, Dnmt3aKO) results in 23,983 DMRs in epidermal cells compared to
wild-type control, Dnmt3aWT. Heatmap representation of WGBS data demonstrates DMRs defined by differences between Dnmt3aWT vs. Dnmt3aKO epidermal cells. Heterozygosity for Dnmt3a (Krt14-Cre+ × Dnmt3afl/+, Dnmt3aHET) results in an intermediate phenotype. Each column represents an independent
mouse. (D) Annotated regions associated with DMRs. *Of 16,315 DMRs involving gene bodies, 3,612 unique genes are involved. (E) Integrated genome viewer
(IGV) view of the G0s2 gene CpG methylation of Dnmt3aWT versus Dnmt3aKO epidermal cells. Normalized methylated CpG reads are represented in bars (scale
0 to 1.0 for each row). Differentially methylated regions are indicated in the bottom track and highlighted in yellow.
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Fig. 2. Single-cell RNA sequencing reveals that Dnmt3a deficiency causes discrete gene expression changes in murine keratinocytes. (A) UMAP representation
of single-cell RNA sequencing data from whole epidermis of two pairs of Krt14-Cre− × Dnmt3afl/fl (Dnmt3aWT; 10,783 cells) and Krt14-Cre+ × Dnmt3afl/fl mice
(Dnmt3aKO;16,324 cells) with unbiased graph-based clustering demonstrating known skin populations represented by lineage defining genes (Right), including HFB, uHF, bIFE, sbIFE, and sebaceous gland (Seb), Krt18-expressing cells (Krt18), proliferative cells (Pro), melanocytes (Mel), T cells (T-cell), and
Langerhan’s cells (Lang). (B) Comparison of keratinocyte lineage cells in the Dnmt3aWT versus Dnmt3aKO mice, excluding inflammatory cells and melanocytes
(excluded clusters 6, 8, 9, and 10). UMAP projections for each pair of samples with the indicated genotypes are shown. (C) No major population shifts are
observed in epidermal lineages affected by Krt14-Cre mediated Dnmt3a deficiency, with the exception that the cells dominated by a proliferative signature
(Pro, cluster M) are increased (6.1% in Dnmt3aKO versus 1.8% in Dnmt3aWT), as indicated by the bar graphs of keratinocyte lineage subclusters. Subclusters of
the hair follicle bulge (A and B), upper hair follicle (C and D), basal interfollicular epidermis (E–G), suprabasal interfollicular epidermis (H–K), and sebocytes (L)
are relatively unchanged. (D) Canonical gene expression changes were noted in single-cell RNA sequencing comparing keratinocyte lineage cells in Dnmt3aWT
versus Dnmt3aKO epidermis (n = 2 mice per genotype). (E) There are 174 differentially expressed genes between Dnmt3aWT and Dnmt3aKO keratinocyte
lineage cells with 137 up-regulated in the Dnmt3aKO and 37 down-regulated genes with fold change >2 and FDR <0.01.
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Differentially Methylated Regions Are Associated with Gene
Expression Changes. Of the 23,983 total DMRs identified by

WGBS, 16,772 were within 10 kb of a gene, representing 5,573
unique genes. Of these, 2,181 genes (39%) were differentially
expressed, as defined by an FDR of <0.01 and fold change >1,
while 47 of these genes had an expression change of greater than
twofold (38 up-regulated, and 9 down-regulated in Dnmt3aKO
cells, Fig. 3A); however, the magnitude of methylation change
was not predictive of expression changes. Further, some genes
(e.g., Krt7 and Meis2) exhibited dramatic but opposing expression changes, despite associated DMRs that were hypomethylated to a similar extent (Fig. 3B). The location of DMRs within
annotated regions (e.g., enhancers, CpG islands, etc.) did not
predict the magnitude or direction of expression changes (SI
Appendix, Fig. S2).
Meis2 is a homeobox transcription factor involved in developmental processes and regulation of tumor proliferation (39),
and Hoxc8 modulates Wnt signaling in the hair follicle niche to
control hair follicle regeneration (40). Both are DMR-associated
genes and are expressed at significantly lower levels in most
Dnmt3aKO epidermal cells (Fig. 3 C and D and SI Appendix, Fig.
S3A), suggesting that the normal expression of these two genes
may be linked to DNA methylation marks added by Dnmt3a. In
contrast, some genes are differentially expressed only in subpopulations of skin cells. For example, Keratin 7 (Krt7), which is
frequently overexpressed in aggressive subtypes of cutaneous
squamous cell carcinoma, and associated with poor survival in
patients with esophageal squamous cell carcinoma (41, 42), is
predominantly expressed in the upper hair follicle in Dnmt3aWT
mice; in Dnmt3aKO mice, its expression increases in the upper
hair follicle as well as the basal and suprabasal interfollicular
epidermis compartments (Fig. 3E and SI Appendix, Fig. S3B).
Similarly, Irx1 is primarily expressed in the hair follicle bulge and
upper hair follicle cells of Dnmt3aWT mice, but its expression
increases in all compartments in Dnmt3aKO mice (Fig. 3F and SI
Appendix, Fig. S3B), a finding that was validated by Western
blotting (Fig. 3G). Decreased methylation in the IRX1 promoter
is associated with increased expression and metastatic capability
in osteosarcoma (43).

Deficiency in Dnmt3a Is Associated with an Increased Fraction of
Cycling Cells in the Skin. The most significant population shift

between Dnmt3aWT and Dnmt3aKO keratinocyte lineage cells
occurred in a cluster that was dominated by the expression of
genes associated with cell division (Figs. 2 B and C and 4A). This
population (cluster M) was defined by the expression of late
interphase cyclins (e.g., Ccna2 and Ccnb2), as well as later cell
cycle genes like Cenpf; these genes are rarely expressed in the
cells of any other clusters (Fig. 4B). The size of this “proliferative
cluster” expanded from 1.8% of total epidermal cells in
Dnmt3aWT mice to 6.1% in Dnmt3aKO mice (3.4-fold, Fig. 4A),
similar to the increase in the fraction of cells expressing Mki67
(from 2.8 to 10.2%, 3.6-fold, Fig. 4C). The expression of cell cycle
genes in cluster M was equally high in Dnmt3aWT and Dnmt3aKO
cells, as expected, since all cells in this cluster are likely to be actively dividing, regardless of their genotype (Fig. 4D); however,
Dnmt3aKO cells in clusters A–L demonstrated increased expression
levels of cell cycle genes, including Mki67 (although the expression
levels of these genes were far lower than that of proliferating cells),
as well as the essential cyclin-dependent kinase Cdk1, which is a
differentially expressed gene associated with a DMR (Fig. 3A). To
validate the proliferative phenotype with an orthogonal method,
we injected 5-bromo-2′-deoxyuridine (BrdU) intraperitoneally into
young (8 to 9 wk old) Dnmt3aWT and Dnmt3aKO mice, and generated single-cell suspensions of epidermal cells 24 h later for flow
cytometric analysis of BrdU uptake. As predicted by the single-cell
RNA-sequencing (scRNA-seq) data, the fraction of actively cycling, Cd45-negative epidermal cells was significantly increased in
the Dnmt3aKO mice (Fig. 4E). Epidermal subpopulations likewise
demonstrated significantly increased BrdU incorporation in
Dnmt3aKO basal interfollicular epidermis cells (and trended upwards in the upper hair follicle); however, no change was detected
in the follicular bulge stem cell compartment, or the postmitotic
suprabasal interfollicular epidermis, neither of which proliferates in
the telogen state (SI Appendix, Fig. S4 A and B).
Focal, Canonical DNA Hypomethylation in the Skin of a Patient with a
Dominant-Negative DNMT3AR882H Mutation. Patients with TBRS

have germline mutations in DNMT3A and exhibit several common clinical features, including overgrowth, characteristic facies,
and neuropsychiatric disorders (44, 45), as well as an increased
risk of developing AML and perhaps other malignancies. We
previously demonstrated that the peripheral blood cells from a
nonleukemic patient with a heterozygous germline DNMT3AR882H
allele exhibited a focal, canonical hypomethylation phenotype
similar to that of AML samples initiated by the same mutation,
suggesting that hypomethylation precedes transformation (30).
To determine whether this mutation causes a methylation
phenotype in human skin, we analyzed DNA methylation in two
skin samples from the same TBRS patient (at ages 9 and 14) and
his unaffected brother (at ages 13 and 17). Global DNA methylation levels were minimally altered (similar to Dnmt3aKO skin).
Nearly all of the 1,234 DMRs identified (1,221/1,234; 98.9%)
were hypomethylated (Fig. 5B); the smaller number of DMRs
(compared to Dnmt3aKO mouse skin) probably reflects the fact that
the R882H mutation is dominant negative (80% reduced activity)
rather than null, and also the reduced power to detect DMRs with
only two samples from each genotype. Plotting the mean methylation values of each DMR between both samples from the two
brothers demonstrated the canonical nature of most of these DMRs
(Fig. 5C). These DMRs were most likely to occur in gene bodies,
similar to that seen in Dnmt3aKO mice (Figs. 1D and 5E).
At many loci, there was a striking similarity in DNA methylation patterns between the DMRs of homologous genes in mice
and humans. For example, DMRs near the homeobox gene IRX3
in human TBRS skin are similar to DMRs near Irx3 in mouse
skin (Fig. 5 D, Left). Another gene important for development,
FZD1, shares a similar methylation phenotype between the TBRS
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was dominated by expression of several genes associated with cellular proliferation (“Pro”), including genes encoding cyclins, cyclindependent kinases, and later cell cycle components like Ube2c,
which encodes part of the anaphase promoting complex (see
Fig. 4 below); this suggests that cells committed to mitosis have a
signature dominated by components necessary for execution of
the cell cycle (38).
The Krt14-Cre conditional knockout of Dnmt3a targets the
epidermal keratinocyte lineages; we therefore excluded skin-infiltrating
hematopoietic cells from subsequent analyses. Keratinocyte
lineage UMAP representations of single-cell data demonstrate a
high degree of similarity among samples, and unbiased clustering
demonstrated similar distributions between populations (Fig. 2B,
clusters A–M). Small, but statistically significant differences in
population sizes between Dnmt3aWT and Dnmt3aKO epidermal
keratinocytes were noted in the follicular bulge cluster 2 and upper hair follicle 1 (clusters B and C), as well as basal and suprabasal interfollicular epidermis (clusters E and I); however, the
most dramatic difference was in the proliferative (Pro) cluster
(cluster M), which is expanded 3.4-fold in Dnmt3aKO skin (1.8%
vs. 6.1%, P = 2.2*10−16, Fig. 2C). In addition to this population
shift, there were canonical gene expression changes associated
with Dnmt3a deficiency (Fig. 2D). In total, there were 174 differentially expressed genes (DEGs) exhibiting a fold change of 2
or greater with a FDR of 0.01 or less. Most of these genes (137)
were more highly expressed in the Dnmt3aKO cells, while 37 were
expressed at lower levels (Fig. 2 D and E).
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Fig. 3. Differentially methylated regions are associated with differentially expressed genes. (A) Heatmap from single-cell RNA sequencing represents the 47
differentially expressed genes between Dnmt3aWT and Dnmt3aKO keratinocyte lineage cells that are associated with a Dnmt3a DMR and exhibit an expression
fold change >2 with an FDR <0.01. Grayscale bars represent cells from independent samples, two from each genotype. (B) Relationship between gene expression and methylation changes between Dnmt3aKO and Dnmt3aWT keratinocytes. There are 5,968 differentially expressed genes with an FDR <0.01, of
these there are 2,181 genes associated with DMRs. This plot represents expression versus methylation of these 2,181 genes. Significant differential expression,
with fold change >2 denoted as red dots. Gray dots represent fold change between 1 and 2. (C) IGV views of differentially methylated regions associated with
Meis2, which has annotated DMRs in CpG islands, shelves, shores, and gene body. Gene expression of Meis2 changes by −5.77-fold (FDR 5.7*10−249).
Dnmt3aKO expresses Meis2 in 172/15,403 (1.11%) of cells compared to Dnmt3aWT 1,106/10,482 (10.6%). (D) Differentially methylated regions associated with
Hoxc8, which has DMRs in shores and gene body. Hoxc8 expression changes by −6.72-fold (FDR 2.51*10−300) and is expressed in 234/15,403 (1.52%) Dnmt3aKO
cells compared to 1,375/10,482 (13.1%) Dnmt3aWT. (E) Differentially methylated regions associated with Krt7, which has DMRs in shores, shelves, promoter,
and gene body. Expression is changed by 7.19-fold in Dnmt3aKO (FDR 9.2*10−182), and cells expressing increase to Dnmt3aKO 2,551/15,403 (16.6%) from
Dnmt3aWT 573/10,482 (5.47%). (F) Differentially methylated regions associated with Irx1, which has DMRs in CpG islands, shores, promoter, and gene body.
Expression is changed by 2.02-fold (FDR 1.16*10−109) in Dnmt3aKO keratinocyte lineage cells, and cells expressing increases from 2,873/15,403 (18.7%)
Dnmt3aKO cells to 885/10,482 (8.44%) Dnmt3aWT. (G) Simple Western demonstrates protein level expression changes in Irx1 and Krt7 from epidermal cells
isolated from the indicated Dnmt3aWT and Dnmt3aKO littermates (bracketed). Actin serves as a loading control.
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Fig. 4. Dnmt3a-deficient keratinocytes exhibit a proliferative phenotype. (A) UMAP of Dnmt3aWT and Dnmt3aKO single-cell RNA sequencing data representing a
pair of samples for each indicated genotype, highlighting the population (in red) identified by unbiased clustering as dominated by expression of genes involved
in cell cycling (cluster M). (B) Proliferative gene expression in the proliferative cluster (cluster M) versus the aggregate of the remaining keratinocyte linage clusters
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skin and mouse Dnmt3aKO skin (Fig. 5 D, Right). The Wnt signaling
pathway is important both for skin and bone development, and
multiple genes of the Wnt pathway also exhibited similar Dnmt3adependent methylation patterns between mouse and human skin
(SI Appendix, Fig. S5). Of the 1,034 DMR-associated genes identified in the TBRS patient, 432 overlapped with Dnmt3aKO DMRassociated genes identified in mouse skin (Fig. 5F).
Discussion
The purpose of this study was to define the baseline epigenetic
characteristics of Dnmt3a-deficient skin. Using WGBS, we defined
the focal, canonical DNA methylation phenotype of Dnmt3adeficient mouse epidermal cells and of a human patient with a
germline DNMT3AR882H mutation. The small changes in the global
methylation state of epidermal cells reflects the restricted places in
the genome where Dnmt3a acts, and the small sizes of these regions
(on average, less than 1 Kb). There were 1,234 DMRs identified in
the skin of the TBRS patient, which affected 3.19% of annotated
gene bodies. Similarly, Dnmt3a-dependent methylation in murine
epidermis occurred most often in gene bodies—more than in

promoters or CpG island shores, which were the next most common
regions affected. However, the magnitude and location of these
differentially methylated regions were not predictive of gene expression changes detected by scRNA-seq. Overall, there were 5,968
DEGs in Dnmt3aKO skin cells, but the number of DEGs that were
close to a DMR (i.e., within 10 Kb) represented a subset of these
genes (2,181/5,968; 36.5%). Only a small subset of these exhibited
an expression fold change of >2 (2.15% of DMR associated DEGs,
0.8% of all DEGs). Like multiple previous studies (18, 30, 46), the
relationship of DMRs to gene expression patterns was unpredictable at a global level, again demonstrating that DNA methylation is
but one factor in determining the expression of a specific gene in a
specific cellular context. Prior studies demonstrated accurate
remethylation of Dnmt3a-dependent DMRs in Dnmt3aKO bone
marrow with induced expression of wild-type DNMT3A, as well as
correction of a subset of gene expression changes (18). However, it
is not yet clear whether remethylation was directly responsible for
altering the expression of these differentially expressed genes.
Aging and sun exposure have been demonstrated to cause DNA
methylation changes, which were particularly apparent comparing
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Fig. 5. A germline, dominant-negative DNMT3A mutation causes focal DNA methylation alterations in human skin. (A) Whole genome bisulfite sequencing
analysis for whole skin samples comparing two samples from a TBRS patient and his brother, comparing CpG methylation globally (Top) or at DMRs (Bottom).
Level of significance * adjusted P < 0.05 and **P < 0.01. (B) Density plots demonstrate global CpG methylation (Top) and CpG methylation at DMRs (Bottom)
in the TBRS patient and his unaffected sibling. (C) Heatmap illustrates 1,234 differentially methylated regions in the skin of the TBRS patient, compared with
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with overexpression (48). Additionally, a model of Dnmt3a deficiency
in KRASG12D driven lung tumors demonstrated that at 24 wk after
induction, Dnmt3aKO tumors were six times larger than their
Dnmt3aWT counterparts and exhibited a markedly higher proliferative
index (49). Together, these findings suggest that epigenetic changes
caused by Dnmt3a deficiency can result in a hyperproliferative state in
several cellular contexts. The specific genes responsible for initiating
this phenotype are not yet clear, but several good candidates
(i.e., Cdk1, Hras, E2f1, and Cdkn1a) are defined in this study (SI
Appendix, Fig. S7 B–D). Proliferative priming may therefore represent
one mechanism that is relevant for the premalignant state associated
with DNMT3A haploinsufficiency or deficiency in multiple tissues.
The resulting expanded proliferative capacity may exist in equilibrium
until cooperating mutations occur, which appear to be essential for
transformation in many model systems.
In addition to clonal hematopoiesis, premalignant mutationdriven clonal expansion has now been shown to occur in many
other systems, including the skin (2), liver (50), esophagus (51, 52),
and bronchial epithelium (53). Mutationally driven, expanded
clones usually do not progress to frank malignancies, suggesting
that additional epigenetic or genetic alterations are required to
cause transformation. In clonal hematopoiesis, the expansion of
hematopoietic stem/progenitor cells is usually caused by mutations
in epigenetic regulatory genes, most commonly in DNMT3A (23,
24, 26, 54). These clonally expanded cells are at increased risk of
transformation to myelodysplastic syndromes or AML, likely by
altering the epigenetic “fitness” of these cells for transformation
(55–57). Similar epigenetic fitness alterations may modify tumor
susceptibility in skin and other organs by a variety of mechanisms.
We identified similarities between the methylation phenotypes
of mice and humans with decreased DNMT3A activity: DMRs in
the epidermis of Dnmt3aKO mice shared considerable gene-level
similarity with a TBRS patient with a germline DNMT3AR882H
mutation. In fact, 432 out of the 1,086 gene-associated DMRs
identified in the skin of this patient overlapped with gene-associated
DMRs found in Dnmt3aKO skin. Several of these overlapping genes
have known roles in development, including IRX3/Irx3; this locus
shares a high degree of evolutionary conservation in noncoding
sequences between human, mouse, and zebrafish, suggesting the
presence and conservation of both functional and regulatory elements (58). Additionally, important pathways in skin development
(like the WNT pathway) have multiple members with similar
DNMT3A/Dnmt3a-dependent methylation patterns (SI Appendix,
Fig. S5). Recent descriptions of AMLs and central nervous system
(CNS) tumors in young patients with germline loss-of-function
DNMT3A mutations strongly suggest that DNMT3A acts as a tumor suppressor in both hematopoietic and CNS cells (59). Although
the skin phenotype and skin cancer susceptibility of children with
TBRS has not yet been described, our data suggest that these patients may be at elevated risk, and that appropriate primary prevention measures should be taken to protect these patients from
sustained UV light exposure. Finally, these data also suggest a role
for DNMT3A in keratinocyte carcinomas arising in aging and sunexposed skin; additional studies to define this role are in progress.
Materials and Methods
Human Studies. Samples were obtained as part of a study approved by the
Human Research Protection Office at Washington University School of
Medicine (approval #201011766), which explicitly allows for potentially
identifying genomic studies, including whole genome sequencing. Written
informed consent was obtained from the parents of the patient with TBRS
(and his unaffected brother) for whole genome bisulfite sequencing studies,
in accordance with the institutional review board approved protocol at
Washington University School of Medicine.
Animals and Epidermal Cell Isolation. All mouse work was performed in accordance with institutional guidelines and approved by the Animal Studies
Committee at Washington University. For all studies, we harvested single-cell
suspensions of dorsal epidermis in second telogen (7 to 10 wk of age), or in
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UV-exposed skin in older patients to UV-protected skin in
younger patients. Large, predominantly hypomethylated blocks
were found to cover 99 Mb of the genome in older, UV-exposed
skin (5). Although the cause of this phenotype is unknown, a
number of possibilities exist, including a progressive decline in
expression (or function) of the DNA methyltransferases, or increased activity of the demethylases (i.e., TET gene family members). In mice, Dnmt1 and Dnmt3a are expressed in the basal layer
of keratinocytes during development; however, in adults, the expression of Dnmt1 is restricted to the hair follicle, and Dnmt3a
expression is restricted to the interfollicular epidermis (8, 11).
Notably, Dnmt3a expression decreases in this compartment in
adult mice (11), though it is not yet clear whether these findings
contribute to the increased risk of skin cancers in elderly patients.
To begin to address this question, Rinaldi et al. demonstrated
that epidermal Dnmt3a deficiency resulted in decreased tumor
latency and increased tumor numbers in mouse skin treated with
DMBA/TPA, suggesting that the threshold for oncogenic transformation is lower in mice with Dnmt3a deficiency (11). In the
same study, mice with Dnmt3b deficiency had no phenotype, and
compound deficiency of Dnmt3a and Dnmt3b (double knockout/
DKO) resulted in tumor latency that was indistinguishable from
that of Dnmt3a deficiency; however, a broader spectrum of tumors arose in the DKO mice, including basal cell carcinomas, as
well as more aggressive tumors (including squamous cell and
spindle cell carcinomas). These tumors developed a reliance on
Pparg; we did not detect up-regulation of Pparg in the premalignant state, suggesting that dysregulation may occur during or after
transformation. In contrast, certain gene expression changes
(i.e., increased expression of G0s2) persisted from the Dnmt3adeficient preneoplastic state to the resulting tumors (11) (Fig. 1E
and Dataset S2). Together, these data strongly suggested that
Dnmt3a deficiency creates a premalignant state for keratinocyte
carcinomas in mice, with some gene expression changes that
persist in tumors. We observed that Dnmt3b deficiency causes
only 20 DMRs in the skin, and that Dnmt3a and Dnmt3b compound deficiency (DKO) adds little to the Dnmt3aKO methylation
phenotype (SI Appendix, Fig. S6). Therefore, in mouse skin,
Dnmt3a is the dominant de novo DNA methyltransferase, and the
loss of its function in aging skin could likewise be relevant for
human skin cancer pathogenesis.
Although Dnmt3a deficiency results in minimal skin population
changes, it is associated with an expanded number of cells with a
proliferative signature in the Dnmt3aKO epidermis. Despite this,
the skin of young mice is not measurably thickened, and spontaneous skin cancers do not occur, suggesting that robust compensatory mechanisms are active. Multiple critical cell cycle genes,
including Ccna2 or Cdk1, are up-regulated in both proliferating
and nonproliferating cells as well; conversely, the cyclin-dependent
kinase inhibitor Cdkn1a is down-regulated in nonproliferating
Dnmt3a-deficient cells (SI Appendix, Fig. S7A). The expression of
Mki67 is tightly regulated and absent in quiescent (G0) cells and
more highly expressed in G2 through M phase cells. Cells that are
more frequently in the cell cycle express higher levels of Mki67
than quiescent cells (47). Indeed, we found that Mki67 expression
is elevated even in the nonproliferating cells of Dnmt3aKO mice,
which may reflect the proliferative history of these cells. Together,
these results suggest that Dnmt3a deficiency may prime epidermal
keratinocytes to enter the cell cycle, or remove antiproliferative
“brakes” from mitogenic signals. While proliferative signaling was
implicated, Cdk1 was the only direct proliferative driver associated
with a DMR and expressed with a fold change >2.
Enhanced proliferation has been observed in the setting of
DNMT3A deficiency in other premalignant and malignant conditions. Decreased DNMT3A expression has been associated
with nonmalignant adenomyosis, where ectopic endometrial cells
invade the myometrium. These cells exhibit increased proliferation with DNMT3A knockdown, and decreased proliferation
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older mice, when skin is >90% telogen based on pale or pink skin color. Details
for mouse strain and epidermal single-cell suspensions can be found in SI
Appendix, Supplementary Materials and Methods.

buffer or suspended in staining buffer for further analysis by flow cytometry. Lysis and staining conditions (as well as antibody information) are described in SI Appendix, Supplementary Materials and Methods.

Whole Genome Bisulfite Sequencing and Analysis. WGBS was performed as
described previously (17) with the exception that DNA was generated from
epidermal cells. Alignment and DMR calling details are in SI Appendix,
Supplementary Materials and Methods.

Data Availability. DNA and RNA sequences (mouse data) have been deposited
in NCBI Sequence Read Archive (BioProject PRJNA674614). Anonymized DNA
sequences (human data) have been deposited in dbGaP (https://www.ncbi.
nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000159.v10.p5).

Single-Cell RNA Sequencing and Analysis. Single-cell suspensions of murine
epidermis were freshly prepared and libraries generated using the 10×
Chromium Controller system. Data analysis was performed using the standard
tools available in the Partek Flow software suite (Partek, Inc.). Full details of
the analysis are in SI Appendix, Supplementary Materials and Methods.
Immunoblotting and Flow Cytometry. Freshly isolated single-cell suspensions
of murine epidermis were lysed in radioimmunoprecipitation assay (RIPA)
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